✦ LIBER ✦

Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma

✍ Scribed by Abad, A.; Masuti, B.; Camps, C.; Font, A.; Balañá, C.; Vicent, J.M.; Sánchez, J.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-intense PEFG (cisplatin, epirubicin

✍ M. Reni; S. Cereda; E. Bonetto; M. G. Viganò; P. Passoni; A. Zerbi; G. Balzano; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 345 KB

Effect of trifluoperazine, a calmodulin

✍ N. P. Larionov; I. A. Feoktistov 📂 Article 📅 1982 🏛 Springer US 🌐 English ⚖ 249 KB

6512 A randomized phase II trial of two

✍ Cereda, S.; Reni, M.; Rognone, A.; Ghidini, M.; Rezzonico, S.; Passoni, P.; Mazz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A randomized phase II trial of two diffe

✍ Michele Reni; Stefano Cereda; Alessia Rognone; Carmen Belli; Michele Ghidini; Si 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 274 KB

Axitinib plus gemcitabine versus placebo

✍ Hedy L Kindler; Tatsuya Ioka; Dirk J Richel; Jaafar Bennouna; Richard Létourneau 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 226 KB

Activity and tolerability of gemcitabine

✍ Heinemann, V.; Wilke, H.; Possinger, K.; Mergenthaler, K.; Clemens, M.; König, H 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 390 KB